| 3.1 |
12.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 2.3 |
6.9 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 1.6 |
4.9 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.2 |
3.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 1.0 |
2.9 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.0 |
4.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.9 |
9.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.8 |
5.3 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.7 |
4.5 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.7 |
2.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.7 |
3.6 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.7 |
11.4 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.7 |
2.0 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.7 |
4.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.6 |
3.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.6 |
2.5 |
GO:0055099 |
regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
| 0.6 |
2.4 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.5 |
2.6 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.5 |
1.5 |
GO:1904059 |
regulation of gastric acid secretion(GO:0060453) regulation of locomotor rhythm(GO:1904059) |
| 0.5 |
1.8 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.4 |
3.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
13.0 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.4 |
2.5 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.4 |
1.2 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.4 |
2.5 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.4 |
2.1 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.4 |
1.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.4 |
4.5 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 |
2.0 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.4 |
1.6 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.4 |
1.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.4 |
1.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.4 |
1.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 |
1.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
2.1 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.4 |
1.8 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.4 |
1.8 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
1.4 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.3 |
1.7 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.3 |
7.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.3 |
0.3 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.3 |
1.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
0.9 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.3 |
0.9 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.3 |
0.9 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.3 |
1.1 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
0.9 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.3 |
2.3 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.3 |
1.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
1.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.3 |
5.8 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.3 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
0.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
1.3 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 |
1.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
0.8 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.3 |
2.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
0.8 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 |
1.8 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
0.5 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
6.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
0.7 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
0.7 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.2 |
1.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
1.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
1.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
0.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 |
1.6 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.2 |
0.7 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
2.5 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
0.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
0.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
2.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
0.6 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.2 |
1.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.8 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.2 |
1.0 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.2 |
0.6 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
0.4 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.2 |
1.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.2 |
1.3 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.2 |
2.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
0.6 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.2 |
0.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 |
0.4 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
1.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
2.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
0.5 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.2 |
3.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
0.9 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
6.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.2 |
0.5 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
1.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
1.0 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.2 |
0.7 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.2 |
0.5 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.2 |
0.8 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
1.6 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.5 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
1.2 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.7 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.1 |
0.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
1.0 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.7 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
1.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.6 |
GO:0097709 |
columnar/cuboidal epithelial cell maturation(GO:0002069) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.1 |
0.5 |
GO:0034238 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 0.1 |
1.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.5 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
1.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.8 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 |
0.5 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
1.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.4 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.4 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.2 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.1 |
2.1 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
1.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
1.8 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 |
1.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
1.0 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 |
0.5 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.4 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.1 |
0.4 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.1 |
0.7 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.1 |
0.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
1.6 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.5 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.8 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
1.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
1.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.8 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
0.7 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.1 |
0.5 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.1 |
0.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
1.6 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.1 |
0.5 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.7 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
0.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.3 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) regulation of mast cell differentiation(GO:0060375) |
| 0.1 |
0.5 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.6 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.3 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
3.1 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
1.0 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.8 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.1 |
0.2 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
1.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
0.3 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.9 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.1 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.1 |
0.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.4 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.6 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 |
1.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
1.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
1.1 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.5 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.1 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
2.8 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
2.5 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
1.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
1.2 |
GO:0045581 |
negative regulation of T cell differentiation(GO:0045581) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.4 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
1.0 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.4 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
2.5 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
0.2 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
1.7 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.1 |
0.2 |
GO:0090195 |
chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.1 |
0.8 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
3.3 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.5 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.1 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.6 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
0.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.1 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 |
1.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.7 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
2.1 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.8 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
1.3 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.1 |
0.6 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
1.3 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
0.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.2 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.9 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
1.1 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.7 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
0.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.3 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
1.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.0 |
0.8 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
8.8 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
1.1 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
1.9 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
1.0 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.2 |
GO:0030049 |
diaphragm contraction(GO:0002086) muscle filament sliding(GO:0030049) |
| 0.0 |
0.4 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.0 |
1.2 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.4 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
1.0 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.6 |
GO:0035148 |
tube formation(GO:0035148) |
| 0.0 |
0.6 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
1.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.2 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.5 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0030952 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.0 |
1.2 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.1 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.0 |
2.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.7 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.2 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.3 |
GO:1901621 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.3 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.6 |
GO:0009952 |
anterior/posterior pattern specification(GO:0009952) |
| 0.0 |
0.1 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 |
0.9 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.2 |
GO:0032733 |
positive regulation of interleukin-10 production(GO:0032733) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.2 |
GO:0006551 |
leucine metabolic process(GO:0006551) branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.5 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
1.4 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.3 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.3 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.0 |
0.2 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.2 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.0 |
0.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.3 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
0.7 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.6 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.2 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.4 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
1.9 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.2 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.6 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.3 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.0 |
0.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.0 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.2 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.2 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.0 |
1.3 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.6 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.5 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.2 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.1 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.7 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.5 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.0 |
1.7 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.0 |
0.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.0 |
0.6 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.0 |
GO:0032650 |
interleukin-1 alpha production(GO:0032610) regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.1 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.4 |
GO:0040008 |
regulation of growth(GO:0040008) |
| 0.0 |
0.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.2 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
0.9 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.8 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.5 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.4 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.5 |
GO:0032869 |
cellular response to insulin stimulus(GO:0032869) |
| 0.0 |
0.2 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.0 |
0.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
